Tasigna Atherosclerosis Lawsuit | Tasigna Peripheral Arterial Disease Lawsuits

National Attorneys Helping Families Nationwide Harmed by Novartis Tasigna

Tasigna Atherosclerosis Lawsuits

Persons and family members of persons who have suffered from Tasigna complications such as atherosclerosis or peripheral arterial disease may be entitled to compensation through filing Tasigna lawsuits against Novartis. Anyone who meets this description is eligible for a free, no-obligation case review with a lawyer handling national Tasigna lawsuits. Tasigna atherosclerosis lawsuits against the Swiss drugmaker Novartis are the best means for individual consumers to hold the pharmaceutical giant accountable. Attorneys handling Tasigna lawsuits work on contingency, meaning you pay nothing unless we win for you. Read full Tasigna lawsuit information from attorneys handling claims nationwide.

Tasigna Lawsuit FAQs

This page provides answers to common questions about filing a Tasigna lawsuit against Novartis. Compiled by our expert drug safety attorneys, the Tasigna lawsuit FAQs page will cover information relevant to most general Tasigna lawsuit questions. To discuss your situation in detail, please contact our firm. One of the lawyers representing national Tasigna lawsuit claims will be happy to speak with you at length and answer your questions. Tasigna side effects lawsuit consultations are free and require no future obligation. Read full Tasigna lawsuit questions and answers.

Tasigna Atherosclerosis Lawyers

Our Tasigna attorneys are experts in the realm of product liability litigation against global pharmaceutical conglomerates like Novartis. Having represented and won compensation for clients in nearly every major drug litigation in recent years, these Tasigna lawyers have the resources and experience to achieve justice in even the most complex of cases. Committed to achieving justice on behalf of American families, our Tasigna atherosclerosis lawyers provide premier legal representation. Contact a Tasigna lawyer for a free, no-obligation case review. Read full Tasigna attorney information for filing a lawsuit against Novartis.

Tasigna Atherosclerosis

Tasigna and atherosclerosis have been linked in numerous prominent studies since 2011. The risk for atherosclerosis from Tasigna was added to the drug's warning label in 2013, yet the American patients and doctors were never directly warned. Tasigna atherosclerosis is a medical condition that leads to a narrowing of the body's arteries, resulting in peripheral arterial disease, limb amputation, cardiovascular problems, and death. This page provides detailed information about Tasigna atherosclerosis including research and warning information. Read full Tasigna atherosclerosis information.

Tasigna Complications

Severe and life-threatening Tasigna side effects have been documented in many peer-reviewed medical journals since 2011, yet American consumers were never warned. Tasigna complications include severe and rapid-onset atherosclerosis, peripheral arterial disease, tissue death and limb amputations, cardiovascular problems and death. This page offers a thorough overview of Tasigna side effects research and global Tasigna warnings. Read full Tasigna side effects information.

Tasigna (nilotinib), among the most popular cancer drugs in the world, has been found to cause rapid, severe and irreversible atherosclerosis, a condition which can result in limb amputation, peripheral arterial disease and cardiovascular problems, and death. Used to treat Philadelphia chromosome-positive chronic myeloid leukemia, Tasigna was linked to atherosclerosis in 2011, yet the American public was not warned of the risk. Through no fault of their own, hundreds of thousands have taken Tasigna, in hopes it would improve their health and completely unaware of the danger of Tasigna atherosclerosis.

Tasigna is manufactured and marketed by the billion dollar pharmaceutical corporation Novartis. Based in Switzerland, Novartis settled a 2013 lawsuit by paying $390 million to the U.S. Department of Justice concerning the payment of illegal kickbacks, misbranding and the use of false advertising claims concerning Tasigna. Novartis has been aware of the Tasigna atherosclerosis risk since 2011, yet purposefully concealed the information from American doctors and patients. By 2013, Novartis had publicly admitted the Tasigna atherosclerosis in Canada, where it issued a Tasigna side effects warning in conjunction with Health Canada; no such warning was issued in the United States. Used to treat chronic myloid leukemia, Tasigna is ranked among the ten most popular cancer drugs in the world; global sales of Tasigna exceeded $1.7 billion in 2016.

If you or a family member was harmed by Tasigna atherosclerosis, you may be eligible to receive compensation through filing a Tasigna lawsuit. Backed by a strong track record in holding pharmaceutical giants accountable for the harm caused by dangerous drugs, these Tasigna lawyers will work tirelessly on your behalf to pursue justice. Contact the firm today for a free, no-obligation Tasigna atherosclerosis case evaluation. Should you choose to retain our Tasigna attorneys, there is never any fee unless we win compensation on your behalf.